Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT
NCT01144754
·
clinicaltrials.gov ↗
TERMINATED
Status
1
Enrollment
OTHER
Sponsor class
Stopped
Low Accrual
Conditions
Lymphoma
Non-Hodgkin's Lymphoma
Interventions
DRUG:
Rituximab
Sponsor
Stanford University